FluoroType® SARS-CoV-2 evo
-For research use only-
Coronavirus Disease 2019 (COVID-19)
In 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a novel pathogenic virus causing coronavirus disease (COVID-19).
As healthcare systems across the world battle this urgent healthcare problem, rapid detection of COVID-19 is essential for outbreak management to help mitigate pressures on healthcare services.
Emerging SARS-CoV-2 variants
Recently, new emerging SARS-CoV-2 variants are of major public concern.
These novel lineages may show increased transmissibility and even bear the risk of immune evasion, therefore posing additional global threats in the attempt to control the viral spread as well as threatening the success of vaccination strategies.
Identifying these variants helps to track their spread and enables epidemiological surveillance.
FluoroType® SARS-CoV-2 evo (RUO)
FluoroType® SARS-CoV-2 evo is a multiplex PCR test for detection of SARS-CoV-2 and simultaneous identification of four different SARS-CoV-2 S gene mutations of interest (K417T, K417N, E484Q and P681R).
The test kit contains reagents for up to 96 reactions. PCR results are produced in under 1.5 hours.
Elaborate Internal Controls (Universal Internal Control 2, available as a separate product) monitor extraction, reverse-transcription and amplification for maximum confidence.
Results at a glance in combination with FluoroCycler® XT
When used in combination with the FluoroCycler® XT, the dedicated FluoroSoftware® XT AssayArea produces an unambiguous report that can be read ‘at a glance’. The wizard-based software comfortably guides users through setup and results evaluation. The Internal Control and software assisted evaluation ensures the generation of reliable results.
Automated nucleic acid extraction for optimal performance
The GenoXtract® and GenoXtract® fleXT nucleic acid extraction systems together with dedicated extraction kits provide high quality nucleic acid extraction for optimal performance.
GenoXtract® allows flexible processing of 1 – 12 samples with ready-to-use reagent cartridges and consumables in a low to medium throughput setting. Users can process samples with confidence thanks to secure sample processing and unique disposable pipetting system, which minimize the potential for contamination. To support medium throughput workflows, multiple instruments can be installed in parallel.
GenoXtract® fleXT is an automated extraction device for high throughput workflows with a flexible option for PCR-plate setup. Up to 96 samples can be processed directly from patient specimens.
Your benefits with FluoroType® SARS-CoV-2 evo (RUO)
- Identification of relevant SARS-CoV-2 S gene mutations: Identification of K417T, K417N, E484Q and P681R via melting curve analysis.
- Detection of SARS-CoV-2: Targeting the RdRP gene for identification of SARS-CoV-2.
- Combination with FluoroCycler® XT provides ‘results at a glance’: Automatically generated reports allow for fast, confident reporting without the need for individual interpretation.
- Workflow supports ease of laboratory implementation: The combination of FluoroType® SARS-CoV-2 evo, FluoroCycler® XT and GenoXtract® or GenoXtract® fleXT provides a user-friendly workflow for ease of implementation in your laboratory.
For Research Use Only. Not for use in clinical diagnostic procedures.
Not all of our products are available in every country. Please contact your local sales representative for availability of this IVD product in your country.
At a glance
Multiplex PCR assay for identification of SARS-CoV-2 S gene mutations
Number of reactions:
GXT NA Extraction Kit (with GenoXtract®)
GXT96 X3 Extraction Kit (with GenoXtract® fleXT)
Instruments for amplification and detection:
FluoroType® SARS-CoV-2 evo No. 1889660
Universal Internal Control 2 No. 402960
GXT NA Extraction Kit No. 12.08.02
Proteinase K Set No. 405002
GXT96 X3 Extraction Kit No. 550960Technology: